Unipharma Limited in Croydon, CR0 3BL

Description

Data updated on: 01-11-2023

Unipharma Limited with reg. no. 09194245 has been on the market for ten years. This particular Private Limited Company is located at 156 Cecil Road, , Croydon and their area code is CR0 3BL. This enterprise's SIC and NACE codes are 96090 meaning Other service activities not elsewhere classified. The most recent filed accounts documents cover the period up to 2022-08-31 and the latest confirmation statement was filed on 2023-08-26.

Regarding this company, the full scope of director's tasks have so far been executed by Arpit P. who was designated to this position in 2014.

Arpit P. is the individual who controls this firm, has substantial control or influence over the company, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2015-08-31	2016-08-31	2017-08-31	2018-08-31	2019-08-31	2020-08-31	2021-08-31	2022-08-31
Currency
Net Worth	10 326	21 447	24 026

Balance Sheet
Current Assets	21 062	54 485	31 394	40 177	34 849	34 936	65 000	89 529
Net Assets Liabilities			24 026	26 159	21 581	19 628	31 703	32 548
Cash Bank In Hand	21 062	54 485
Net Assets Liabilities Including Pension Asset Liability	10 326	21 447	24 026
Tangible Fixed Assets	487	366

Capital & Reserves
Called Up Share Capital	2	2
Profit Loss Account Reserve	10 324	21 445
Shareholder Funds	10 326	21 447	24 026

Other Financial Data
Average Number Employees During Period				2	2	2	2	2
Creditors			7 642	14 224	13 422	15 424	33 384	57 046
Fixed Assets	487	366	274	206	154	116	87	65
Net Current Assets Liabilities	9 839	21 081	23 752	25 953	21 427	19 512	31 616	32 483
Total Assets Less Current Liabilities	10 326	21 447	24 026	26 159	21 581	19 628	31 703	32 548
Creditors Due Within One Year	11 223	33 404	7 642
Tangible Fixed Assets Additions	650
Tangible Fixed Assets Cost Or Valuation	650	650
Tangible Fixed Assets Depreciation	163	284
Tangible Fixed Assets Depreciation Charged In Period	163	121

Company staff

Arpit P.

Role: Director

Appointed: 29 August 2014

Latest update: 23 March 2024

People with significant control

Arpit P.

Notified on 1 August 2016

Nature of control:

substantial control or influence

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	31 May 2024
Account last made up date	31 August 2022
Confirmation statement next due date	09 September 2024
Confirmation statement last made up date	26 August 2023

Annual Accounts 16 May 2016
Start Date For Period Covered By Report	2014-08-29
End Date For Period Covered By Report	2015-08-31
Date Approval Accounts	16 May 2016
Annual Accounts 30 May 2017
Start Date For Period Covered By Report	2015-09-01
End Date For Period Covered By Report	2016-08-31
Date Approval Accounts	30 May 2017
Annual Accounts 29 May 2018
Start Date For Period Covered By Report	2016-09-01
End Date For Period Covered By Report	2017-08-31
Date Approval Accounts	29 May 2018
Annual Accounts
Start Date For Period Covered By Report	2017-09-01
End Date For Period Covered By Report	2018-08-31
Annual Accounts
Start Date For Period Covered By Report	2018-09-01
End Date For Period Covered By Report	2019-08-31
Annual Accounts
Start Date For Period Covered By Report	2019-09-01
End Date For Period Covered By Report	2020-08-31
Annual Accounts
Start Date For Period Covered By Report	2020-09-01
End Date For Period Covered By Report	2021-08-31
Annual Accounts
Start Date For Period Covered By Report	2021-09-01
End Date For Period Covered By Report	2022-08-31

Unipharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Arpit P.

People with significant control

Arpit P.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies